Showing results (81-90 of 105) with videos related to
Sort By:
Pageof 11
Neuro-Oncology Advances|March 9, 2026
<i>BRAF</i>-mutant high-grade glioma with pleomorphic and pseudopapillary features (HPAP): A PLNTY mimic demonstrating tumor progression during longitudinal follow-upYutaro Takayama, Mariko Yaegashi, Kaishi Satomi, et al.Brain Tumor Pathology|May 20, 2025
Rapidly progressive scalp and lung metastases with fatal pneumothorax in glioblastoma, IDH-wildtype, with MET and CDK6 amplifications: a case report of clinical course and postmortem autopsy, including genetic analysisYoshihiro Tsukamoto, Manabu Natsumeda, Hiroshi Shimizu, et al.Brain Tumor Pathology|March 21, 2022
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study GroupKenichiro Asano, Yoji Yamashita, Takahiro Ono, et al.Pediatric Blood & Cancer|January 10, 2025
Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal FluidSatoshi Shibuma, Jotaro On, Manabu Natsumeda, et al.Journal of Neuro-Oncology|January 16, 2024
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumorsJotaro On, Manabu Natsumeda, Haruhiko Takahashi, et al.Current Oncology (Toronto, Ont.)|April 26, 2024
Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant FeaturesDaiken Satake, Manabu Natsumeda, Kaishi Satomi, et al.Cancer Science|October 3, 2025
IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational ScopeAki Ogawa-Iio, Koh Takeuchi, Keita Shigemi, et al.Journal of Neurosurgery. Case Lessons|October 23, 2023
Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative casesYoshihiro Tsukamoto, Manabu Natsumeda, Haruhiko Takahashi, et al.Brain Tumor Pathology|September 22, 2025
Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrenceFarida Garaeva, Riho Nakajima, Sho Tamai, et al.International Journal of Clinical Oncology|September 29, 2021
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative studyTomokazu Aoki, Naoki Kagawa, Kazuhiko Sugiyama, et al.Pageof 11